...
首页> 外文期刊>Frontiers in Pharmacology >Evolution to a Competency-Based Training Curriculum for Pharmaceutical Medicine Physicians in Switzerland
【24h】

Evolution to a Competency-Based Training Curriculum for Pharmaceutical Medicine Physicians in Switzerland

机译:在瑞士发展为以药学为基础的以能力为本的培训课程的医师

获取原文
           

摘要

In Switzerland, Pharmaceutical Medicine has existed as one of 46 physician specialties accredited by the Federal Office of Public Health for more than 20 years. As a medical-scientific discipline, our goal is to enable best possible therapeutic coverage for the benefit of patients and society through a medical need-based development and optimal use of medicinal products. The role of the specialist in Pharmaceutical Medicine is to closely collaborate with various stakeholders of the healthcare system in the context of the discovery, research, development and approval of new medicinal products, as well as safe and effective use of new and established medicinal products in daily clinical practice. The post-graduate training consists of 2 years of patient-related clinical work, followed by 3 years of vocational training at certified training centers in Pharmaceutical Medicine. This also includes completion of an academic post-graduate diploma in Pharmaceutical Medicine (30 ECTS) according to the IFAPP/PharmaTrain syllabus and a 1 day board exam. As part of an ongoing revision of the training curriculum, we are developing a Swiss Catalog of Core Competencies in Pharmaceutical Medicine (SC ~(3)-PM), based on the IFAPP competency framework for drug development specialists in industry. In this article we discuss how we adapt the scope of the IFAPP competency framework to better reflect such roles in academic institutions or regulatory bodies in Switzerland.
机译:在瑞士,药物医学已成为联邦公共卫生局认可的46种医师专业之一,已有20多年的历史。作为医学科学学科,我们的目标是通过基于医疗需求的开发和药物的最佳使用,实现对患者和社会的最大可能的治疗覆盖。药物医学专家的作用是在新药物的发现,研究,开发和批准以及安全有效地使用新的和已建立的药物的背景下,与医疗体系的各个利益相关者紧密合作。日常临床实践。研究生培训包括2年与患者相关的临床工作,然后是经过认证的药学医学培训中心的3年职业培训。这还包括根据IFAPP / PharmaTrain教学大纲完成药学专业的学术研究生文凭(30 ECTS)和1天的董事会考试。作为不断修订的培训课程的一部分,我们正在根据IFAPP针对行业中药物开发专家的能力框架,制定《瑞士药物医学核心能力目录》(SC〜(3)-PM)。在本文中,我们讨论了如何调整IFAPP能力框架的范围,以更好地反映瑞士学术机构或监管机构中的此类角色。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号